|
8151 |
The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia
Enthalten in Psychopharmacology Bd. 170, 10.9.2003, Nr. 4, date:12.2003: 423-428
|
|
|
|
8152 |
The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol
Enthalten in Nutrition journal Bd. 18, 31.8.2019, Nr. 1, date:12.2019: 1-13
|
|
|
|
8153 |
The synergistic effect of vitamin D supplement and mindfulness training on pain severity, pain-related disability and neuropathy-specific quality of life dimensions in painful diabetic neuropathy: a randomized clinical trial with placebo-controlled
Enthalten in Journal of diabetes & metabolic disorders Bd. 20, 2.1.2021, Nr. 1, date:6.2021: 49-58
|
|
|
|
8154 |
The TEMP-PREVENT trial: a study protocol for a randomized, double-blind, placebo-controlled clinical trial of etidronate for treatment in young adult patients with pseudoxanthoma elasticum
Enthalten in Trials Bd. 26, 23.10.2025, Nr. 1, date:12.2025: 1-8
|
|
|
|
8155 |
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
Enthalten in The journal of headache and pain Bd. 24, 16.5.2023, Nr. 1, date:12.2023: 1-18
|
|
|
|
8156 |
The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials – A secondary analysis
Enthalten in BMC medical research methodology Bd. 5, 18.8.2005, Nr. 1, date:12.2005: 1-12
|
|
|
|
8157 |
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial
Enthalten in Trials Bd. 21, 29.6.2020, Nr. 1, date:12.2020: 1-11
|
|
|
|
8158 |
The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome
Enthalten in BMC musculoskeletal disorders Bd. 15, 17.1.2014, Nr. 1, date:12.2014: 1-10
|
|
|
|
8159 |
The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial
Enthalten in Nature medicine Bd. 30, 2.8.2024, Nr. 8, date:8.2024: 2295-2302
|
|
|
|
8160 |
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders—a double-blind, randomized, placebo-controlled proof-of-concept study
Enthalten in Trials Bd. 25, 22.4.2024, Nr. 1, date:12.2024: 1-14
|
|
Administration
